ZURICH, Sept 24 Novartis on Thursday named Harvard Medical School cancer specialist James Bradner as head of biomedical research with a seat on its executive committee as of March 2016.
Bradner succeeds Mark Fishman, who is retiring after a 13-year stint leading the Swiss company's drug discovery and early clinical development efforts.
20:27 The best hire Indiana could have made: Hoosiers opt for quality over nostalgia with Dayton's Archie Miller17
22:22 Report: Tony Romo believes it's Texans or retirement in 20176
18:15 Will alum Patrick Ewing be Georgetown Hoyas' next head coach?19
14:04 New flexible glass to bolster tiny medical devices26